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The phenotype of developing liver NK cells (CD3−NK1.1+) was investigated during mouse ontogeny comparing with spleen NK
cells. The highest percentage of hepatic CD27−CD11b− NK cells occurred at the fetal stage. After birth, the percentage of CD27−
CD11b−NKcellsinboththeliverandspleengraduallydecreasedtotheirlowestlevelat6weeks.MoreCD27+CD11b−NKcellswere
detected in the liver than that in spleen from week 1 to 6. Expression of NKG2A on liver NK cells was decreased but still much
higherthanthatofspleenNKcellsafter1week.TheNKG2DexpressiononliverNKcellsincreasedtoitshighestlevelandwassigni-
ﬁcantlyhigherthanonspleenNKcellstill4weeks.Duringmouseontogeny,weakerexpressionofNKp46andCD2andstrongerex-
pression of CD69, CD11c, 2B4, and CD73 were observed on liver NK cells. Furthermore, neonatal liver NK cells express higher
IFN-γ andperforinthanadult.TheseresultssuggestthatthematurationprocessofNKcellsisuniqueinthelivers,andlivermicro-
environments might play critical roles to keep NK cells in an immature status.
1.Introduction
NK cells are derived from haematopoietic stem cells (HSCs).
TheprecursorsofNKcellsaregeneratedinthebonemarrow;
they are committed to the NK cell lineage and develop into
m a t u r eN Kc e l l sw i t hf u l le ﬀector function and heterogene-
o u sp h e n o t y p e s[ 1, 2]. The deﬁnitive site(s) for NK cell de-
velopment can only be inferred from where immature and
mature NK cells have been detected. NK cell precursors
(NKPs) are found in diﬀerent organs, such as bone marrow,
fetal thymus, lymph node (LN), liver, spleen, and peripheral
blood, whereas immature NK (iNK) cells are found in the
bone marrow, liver, and spleen [3]. It is unknown whether
these developmental intermediates leave the bone marrow to
completetheirdiﬀerentiationelsewhere,suchastheliverand
spleen.
In liver, but not spleen, a unique subset of immature NK
cells constitutively express tumour necrosis factor-related
apoptosis-inducing ligand (TRAIL) and low levels of mature
NK cell markers, such as the Ly49 receptors and CD11b [4–
8]. A subset of NK-cells highly expressing CD11c have also
been found speciﬁcally in the liver [9]. Adoptive transfer
of either adult or neonatal mouse liver TRAIL+ NK cells
results in the appearance of TRAIL− NK cells with a mature
phenotype,suggestingthattheseTRAIL+ NKcellsintheliver
were indeed a precursor subset [4]. Stromal cells in various
organs send signals through cytokines, receptors, and tran-
scription factors that inﬂuence the ultimate phenotypes and
functions of NK cell precursors [2, 10–15], suggesting that
there may be speciﬁc developmental pathways for intrahepa-
tic NK cells. D. M. Andrews and M. J. Smyth have described
diﬀerencesintheaccumulationofNKcellsubsetsintheliver,
bone marrow, spleen, and lung between WT B6 mice and
Rag1−/− mice during weeks 1–5 and at 8 weeks of age.
Costaining of CD27 and CD11b were used to divide
NK1.1+CD3− NK cells into four subsets that were at diﬀe-
rent maturation stages [16]. The ﬁrst appearance of mature
CD27−CD11b+ NK cells in these organs, including bone
marrow, spleen, and lung, occurs at 3 weeks of age, and mat-
uration is complete by 8 weeks of age. Complete maturation
of hepatic NK cells occurs at 2 weeks of age, with fewer
CD27−CD11b+ NK cells accumulating in the adult mouse
liver. These results demonstrate that the liver displays slow-
er kinetics in the accumulation of terminally mature2 Clinical and Developmental Immunology
CD27−CD11b+ NK cells. Furthermore, in neonatal Rag1−/−
mice, NK cells are absent in bone marrow and spleen, but
a precursor NK cell subset is found in the liver, and normal
NK cells without functional deﬁciencies can be detected in
adult Rag1−/− mice. It was hypothesised that liver NK cells
developindependentlyoutofthebonemarrowandthatRag-
1hasasigniﬁcantroleinNKcelldevelopment[17,18].These
resultshavehelpedustounderstandtheuniquedevelopment
pathway of liver NK cells; however, the details of phenotypes
of developing liver NK cell subsets during mouse ontogeny
have not been fully elucidated.
In our study, NK cell development in liver was explored
and compared with NK cell development in spleen during
mouse ontogeny. We found an abundance of NKPs, but the
development pathway did not occur concurrently in the liver
and spleen. The CD27−CD11b− NK cell precursors accumu-
lated predominantly in the adult liver and not in the spleen.
In the liver, more immature NK cells were present, which
express a higher level of NKG2A and lower levels of Ly49 re-
ceptors. Additionally, diﬀerent stimulatory receptors and ad-
hesion molecules were expressed on NK cells in the liver and
spleen during ontogeny. And the expression level of IFN-
gamma and perforin were higher of neonatal liver NK cells
comparing with 10-week-old liver NK cells. These results
indicate that there might be a speciﬁc developmental path-
way of NK cells in the liver and that the microenvironments
play important roles in NK cell development and diﬀerenti-
ation.
2. Results
2.1. Maturation of Liver NK Cells Is Diﬀe r e n tf r o mT h a to f
Spleen NK Cells during Ontogeny. Based on the expression of
CD11b and CD27, NK cells (NK1.1+CD3−)c a nb ed i v i d e d
into four subsets at diﬀerent maturation stages [16, 19]. The
gatingstrategyisshowninFigure1ofSupplementaryMater-
ial available at doi 10.1155/2012/759765. As the most im-
mature subset, CD27−CD11b− NK cells are the precursors
of the other three NK cell subsets [16]. As shown in Figure 1,
thehighestpercentageofCD27−CD11b− NKcellsintheliver
occurred at embryonic day 20 (E20) (35.38 ± 0.64%). Com-
paratively, the percentage of CD27−CD11b− NK cells was
muchlowerinthespleenofE20mice(14.62 ± 3.19%).How-
ever, the percentage of CD27−CD11b− NK cells increased
markedly to their highest level in the spleen of neonatal mice
(29.73 ± 6.50%), which was similar to that found in the liver
(Figure 1). As the mice growth, the percentage of CD27−
CD11b− NK cells in the spleen and liver decreased markedly,
reaching a nadir at week 6 (4.91 ± 0.74% and 8.97 ± 3.51%,
resp., Figure 1), but CD27−CD11b− NK cells increased
markedlyinthelivertotheirhighestlevelsoncemoreatweek
8 to 10 (24.64 ± 2.66% and 31.53 ± 5.13%, resp.). These
results indicate that CD27−CD11b− NK precursor cells re-
side predominantly in the adult liver and not in the spleen.
Subsequently, in the liver of E20 mice, the percentage of
immature CD27+CD11b− NK cells was signiﬁcantly lower
than in the spleen (37.61 ± 1.51% versus 57.57 ± 0.007%,
P = 0.0029, Figure 1). From week 1 to 6, there was higher
percentage of CD27+CD11b− NK cells in the liver compared
with the spleen. At 8 weeks of age, no signiﬁcant diﬀerence
in the percentage of CD27+CD11b− NK cells was found
between the liver and spleen of adult mice.
CD27+CD11b+ NKcellsandCD27−CD11b+ NKcellsare
mature NK cells [5]. In the liver, the percentage of CD27+
CD11b+ NK cells remained at a steady level, while in the
spleen, this NK cell subset increased to a higher percentage
during ontogeny. At 6 weeks of age, the percentage of CD27+
CD11b+ NK cells in the spleen of the adult mice was 41.93 ±
4.58%, but the percentage of CD27+CD11b+ NK cells in the
liver was only 26.73 ± 2.28% (Figure 1), which is similar to
levels found in 8- to 10-week-old mice. In 3-day-old mice,
thepercentageofmatureCD27−CD11b+ NKcellsintheliver
was higher than in the spleen (21.18 ± 1.67% versus 11.48 ±
1.51%, P = 0.0017, Figure 1) ,b u tf r o mw e e k s1t o4 ,t h ep e r -
centages in the liver and spleen were reversed. In the 6-week-
oldadultmice,thepercentagesofCD27−CD11b+ NKcellsin
the liver and spleen were similar (31.48 ± 1.86 and 34.85 ±
6.17, resp., P = 0.4161, Figure 1).
These results indicate that the maturation process is dif-
ferent in liver and spleen. In each organ of neonatal mice,
there was a high percentage of NK cell precursors, but the
liver NK cell development did not occur in parallel to spleen
NK cells. In the liver, there were more immature NK cells.
2.2. Developing NK Cells Expresses Diﬀerent Inhibitory and
Stimulatory Receptors in the Livers When Compared with
Spleen during Ontogeny. As shown in Figures 2(a) and 2(b),
at the earliest stage of development, almost all NK cells were
NKG2A-positive in the liver and spleen (95.71 ± 1.07% and
90.98 ± 1.95%, resp., Figure 2). With further development,
the percentage of NKG2A+ NK cells gradually decreased, but
the decrease in liver was delayed compared with spleen. In
10-week-old adult mice, 59.16 ± 3.36% of NK cells were
NKG2A+ in liver, compared to 45.05 ± 1.11% in spleen
(Figure 2). NK cells gradually acquired expression of Ly49
receptors, which are markers delineating the maturation
stages of NK cells [3]. In the livers from fetal and neonatal
mice, only 7.81 ± 5.31% and 6.04 ± 1.98% of NK cells,
respectively, were Ly49C/I/F/H+ (Figure 2). Of note, in 3-
day-old mice, the percentage of Ly49C/I/F/H+ NK cells in
the liver rapidly increased to 17.36 ± 2.50% (Figure 2),
which was signiﬁcantly higher than in spleen (5.01 ± 0.61%,
Figure 2). However, at 1 week the expression of Ly49 C/I/F/H
on spleen NK cells rapidly increased, and after 4 weeks, the
expression level in the liver was markedly lower than in the
spleen.Theseresultsfurtherindicatethatthedevelopmentof
NKcellsdidnotoccurconcurrently.Intheliver,NKcellshad
phenotypes characteristic of immature subsets.
To further investigate the functions of NK cells at dif-
ferent developmental stages in the liver and spleen, a series of
stimulatory receptors was detected by ﬂow cytometry. From
the mean ﬂuorescence intensity and percentage in both liver
and spleen of fetal and neonatal mice, the expression of
NKG2D on NK cells was very low (Figure 3(a)). At later de-
velopmental stages,the expression of NKG2D wasupregulat-
ed. In liver, the expression of NKG2D increased to its highestClinical and Developmental Immunology 3
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Figure 1:DiﬀerentmaturationstagesofNKcellsaccordingtoexpressionlevelsofCD27andCD11b.Flowcytometryanalysiswasperformed
to analyse lymphocytes from the liver and spleen of B6 mice at the ages of E20, the neonatal stage, and at 3 days, 1 week, 3 weeks, 4 weeks, 6
weeks,8weeks,and10weeks,whichwerestainedwiththeindicatedantibodies.NKcells(CD3−NK1.1+)weregatedtoanalysetheexpression
of CD27 and CD11b. Six to seven fetal mouse livers or spleens were put together to acquire enough cells to perform FACS analysis in one
experiment, and three independent experiments were performed. In the other groups, there were three mice independently detected for
one experiment, and three independent experiments were performed. (a) The percentages represent the net percentage (%) of cells in the
appropriate quadrant. These are from a single experiment representative of three independent experiments. (b) The percentages of four
NK cell subsets in the liver and spleen were calculated. Data are shown as the mean ± SEM from three mice in each group. ∗∗∗P<0.001,
∗∗P<0.01, ∗P<0.05.4 Clinical and Developmental Immunology
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Figure 2: Diﬀerent expression patterns of the NKG2A/Ly49 family of receptors on NK cells during mouse ontogeny. Flow cytometry was
performed to analyse the lymphocytes stained with indicated antibodies from liver and spleen of B6 mice at E20, the neonatal stage, and at
3 days, 1 week, 3 weeks, 4 weeks, 6 weeks, 8 weeks, and 10 weeks. NK cells (CD3−NK1.1+) were gated to analyse the expression of NKG2A
and Ly49. In each independent experiment, six to seven fetal mouse livers/spleens were put together to acquire enough cells to perform
FACS analysis, and independent experiments were repeated for three times. (a) The percentages represent the net percentage (%) of cells in
the appropriate quadrant. These are from a single experiment representative of three independent experiments. (b) The percentages of the
NKG2A+ NK cell subset (%) and the Ly49+ NK cell subset (%) were calculated from the total number of NK cells in the liver and spleen.
Data are shown as the mean ± SEM from three mice in each group. ∗∗∗P<0.001, ∗∗P<0.01, ∗P<0.05 compared with the corresponding
group.Clinical and Developmental Immunology 5
∗∗
∗∗
∗∗
∗∗
∗∗ ∗∗ ∗∗
∗∗
∗∗∗
∗∗∗
Fetal Neonatal 3 days 1 week 4 weeks 5 weeks
5
w
e
e
k
s
5
w
e
e
k
s
6 weeks 8 weeks 10 weeks
0
20
40
60
80
100
NKG2D
M
F
I
o
f
N
K
G
2
D
E
v
e
n
t
s
0
10
20
30
40
50
F
e
t
a
l
N
e
o
n
a
t
a
l
3
d
a
y
s
1
w
e
e
k
4
w
e
e
k
s
8
w
e
e
k
s
1
0
w
e
e
k
s
6
w
e
e
k
s
F
e
t
a
l
N
e
o
n
a
t
a
l
3
d
a
y
s
1
w
e
e
k
4
w
e
e
k
s
8
w
e
e
k
s
1
0
w
e
e
k
s
6
w
e
e
k
s
∗
∗
N
K
G
2
D
+
N
K
c
e
l
l
(
%
)
(a)
Fetal Neonatal 1 week 3 weeks 4 weeks 6 weeks 8 weeks 10 weeks
NKp46
M
F
I
o
f
N
K
p
4
6
E
v
e
n
t
s
0
20
40
60
80
100
0
50
100
150
200
F
e
t
a
l
N
e
o
n
a
t
a
l
1
w
e
e
k
4
w
e
e
k
s
3
w
e
e
k
s
3
w
e
e
k
s
8
w
e
e
k
s
1
0
w
e
e
k
s
6
w
e
e
k
s
F
e
t
a
l
N
e
o
n
a
t
a
l
1
w
e
e
k
4
w
e
e
k
s
8
w
e
e
k
s
1
0
w
e
e
k
s
6
w
e
e
k
s
∗
∗
∗ ∗
∗∗
∗∗
N
K
p
4
6
+
N
K
c
e
l
l
(
%
)
(b)
Fetal Neonatal 3 days 1 week 3 weeks 6 weeks 8 weeks 10 weeks
2B4
M
F
I
o
f
2
B
4
E
v
e
n
t
s
0
200
400
600
Liver
Spleen
Liver
Spleen
F
e
t
a
l
N
e
o
n
a
t
a
l
3
d
a
y
s
1
w
e
e
k
4
w
e
e
k
s
8
w
e
e
k
s
1
0
w
e
e
k
s
6
w
e
e
k
s
3
w
e
e
k
s
∗∗
∗∗
∗∗∗
∗∗∗
∗∗∗
(c)
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Figure 3:StimulatoryreceptorsexpressedonNKcellsduringmouseontogeny.Attheindicatedtimepoints,mononuclearcellswereisolated
from liver and spleen and analysed by ﬂow cytometry for the expression of stimulatory receptors. NK cells (NK1.1+CD3−)w e r eg a t e d ,a n d
each marker was analysed by histogram. Unstained controls are shown in grey. The expression of NKG2D (a), NKp46 (b), 2B4 (c), and CD2
(d) on liver NK cells is shown and compared with spleen NK cells during ontogeny. In each independent experiment, six to seven fetal mouse
livers or spleens were put together to acquire enough cells to perform FACS analysis in one experiment, and three independent experiments
were performed. In the other groups, there were three mice independently detected for one experiment, and three independent experiments
were performed. The mean ﬂuorescence intensity (MFI) and positive percentage of each marker are shown as mean ± SEM from three mice
in each group. These are from a single experiment representative of three independent experiments. ∗∗∗P<0.001, ∗∗P<0.01, ∗P<0.05
compared with the corresponding group.
level at 4 weeks and was signiﬁcantly higher than in spleen,
while in spleen, NKG2D increased to its highest level at 8
weeks. This result indicates that earlier expression of the
stimulatory NKG2D receptor in hepatic NK cells might be
associated with their speciﬁc function in the liver. At 8 to 10
weeks,theexpressionlevelofNKG2DonliverNKcells(51.14
± 5.18% and 53.01 ± 6.2%, resp.) was signiﬁcantly lower
than in spleen (64.56 ± 3.58% and 71.68 ± 3.10%, resp.,
Figure 3(a)). As shown in Figure 3(b), there was no signif-
icant diﬀerence in the percentage of NKp46-expressing NK
cells between liver and spleen. From newborn to adult mice,
NKp46 was expressed on almost all NK cells in the liver and
spleen, but the ﬂuorescence intensity of NKp46 expression
was much weaker in the liver compared with the spleen.
In addition, we found that all NK cells in both the liver
and spleen expressed 2B4 and CD2; however, the ﬂuores-
cence intensity diﬀered between the two tissues (Figures 3(c)
and3(d)).Intheearlierstageofontogeny,fromthefetalstage
to 3 weeks after birth, the expression level of 2B4 on NK cells
in liver was consistent with a high MFI, while 2B4 expression
on NK cells in spleen decreased markedly after the neonatal
stage (Figure 3(c)). At 6 weeks of age, the expression of 2B4
on NK cells in adult mice decreased to a nadir in both liver
and spleen. During ontogeny, the expression of CD2 on NK
cells in liver and spleen was relatively stable, and the expres-
sion of CD2 on NK cells in the liver was signiﬁcantly lower
than in the spleen (Figure 3(d)). Diﬀerent inhibitory and
stimulatory receptors were expressed on NK cells in the liver
compared with the spleen during ontogeny, which may be
related to the speciﬁc functions of NK cells in diﬀerent
organs.
2.3. Higher Expression of Function-Related Molecules on Liver
NKCellsComparedwithSpleenNKCellsduringOntogeny. In
the foetus, liver and spleen NK cells exhibited elevated expre-
ssion of CD69 (71.18 ± 3.05% and 69.75 ± 3.68%, resp.,
Figure 4). At later stages of development, the expression
of CD69 on NK cells in the liver was upregulated to reach
a maximum at 3 weeks, while in the spleen, the expression
was downregulated after the neonatal stage. Although the
percentage of CD69-expressing NK cells in the liver decreas-
ed to 50.07 ± 4.65% at 8 weeks of age, it remained signiﬁ-
cantly higher than in the spleen (10.33 ±1.14%); similar per-
centages were found in 10-week-old mice (53.23 ± 2.42%
and 10.29 ± 1.62%, resp., P<0.0001, Figure 4). The re-
sults obtained with dynamic MFI further conﬁrmed higher
expressionofCD69onliverNKcellsduringmouseontogeny
(Figure 4(b)).
Additionally, the diﬀerential expression pattern of adhe-
sion molecules distinguished liver NK cells from spleen NK
cells. CD11c was expressed more highly on liver NK cells
than on spleen NK cells during mouse ontogeny, except
in fetal mice (Figure 5(a)). The highest level of CD11c on
liver NK cells was observed at 4 weeks, but it decreasedClinical and Developmental Immunology 7
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Figure 4:TheexpressionlevelofCD69onliverNKcellsishigherthanonspleenNK.Flowcytometrywasperformedtoanalyselymphocytes
stained with the indicated antibodies from liver and spleen of B6 mice at E20, the neonatal stage, and at 3 days, 1 week, 3 weeks, 4 weeks,
6 weeks, 8 weeks, and 10 weeks. NK cells (CD3−NK1.1+) were gated to analyse the expression of CD69. In each independent experiment,
six to seven fetal mouse livers or spleens were put together to acquire enough cells to perform FACS analysis in one experiment, and three
independent experiments were performed. In the other groups, there were three mice independently detected for one experiment, and three
independent experiments were performed. (a) Each percentage represents the net percentage (%) of cells in the appropriate quadrant. These
results are from a single experiment representative of three independent experiments. (b) The percentages of the CD69+ NK cell subset (%)
were calculated for the total number of NK cells in the liver and spleen. Data are shown as mean ± SEM from three mice in each group.
∗∗∗P<0.001, ∗∗P<0.01, ∗P<0.05 compared with the corresponding group.
in adult mice (Figure 5(a)). Similarly, CD73 was expressed
more highly on liver NK cells, reaching its highest level at 3
weeks (Figure 5(b)).
To further explore the functions of hepatic NK cells at di-
ﬀerent developmental stages, hepatic MNCs were stimulated
with Poly I:C in vitro, and then the expressions of IFN-
gamma, perforin, and Granzyme B of NK cells were tested.
AfterstimulatedwithPolyI:Cinvitro,thereweremoreIFN-
gamma and perforin expressed by the neonatal liver NK cells
than 10-week old liver NK cells (P = 0.0082 and P = 0.0009)
(Figure 6). However, there were no signiﬁcant diﬀerences of
theexpressionofGranzymeBbetweenneonatalliverNKcells
and 10-week-old liver NK cells (Figure 6). It suggested that
the function of neonatal liver NK cells may stranger than
adult liver NK cells.
3. Discussion
The phenotypes and functions of NK cells change with age
and location [12]. There is a unique intrahepatic NK cell
subset with the immature phenotype of NKG2A+Ly49s−
DX5−TRAIL+ [4–6, 8, 17, 18]. A large body of evidence has
supported the existence of a speciﬁc development pathway of
NK cells in liver [4, 17, 18]. In our study, we described the
development of NK cells in liver compared with spleen dur-
ing mouse ontogeny.
There is a signiﬁcantly higher percentage of the CD27−
CD11b− NK cell subset in liver than in spleen in adult wild-
type C57BL/6 mice [18–20] ,w h i c hw ec o n ﬁ r m e di no u r
study (Figure 1). Furthermore, our study is the ﬁrst to des-
cribethepresenceofahighpercentageoftheCD27−CD11b−
NK cell subset in fetal mouse liver and to demonstrate that
thepercentageofthisNKcellsubsetwaspersistentlyelevated
in the adult liver during ontogeny (Figure 1). Because the
fetal liver is the major haematopoietic organ during embryo-
genesis, we speculate that the CD27−CD11b− NK cell subset
originated from the fetal liver. The NK cell population is
absent in bone marrow and spleen from neonates of Rag1−/−
mice but accumulates in bone marrow and spleen of adult
mice. Additionally, an overrepresentation of CD27−CD11b−
NK cells, which are considered a precursor NK cell subset
found normally in the liver, is observed in the bone mar-
row of Rag1−/− mice. This suggests that liver NK cell precur-
sors might seed into other organs to compensate for the
absence of bone marrow-derived NK cells [17]. The pre-
dominant NK cell subsets in the spleen were of the mature
phenotypes, CD27+CD11b+ and CD27−CD11b+(Figure 1),8 Clinical and Developmental Immunology
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Figure 5: Adhesion molecules expressed on NK cells during mouse ontogeny. At the indicated time points, mononuclear cells were isolated
from the liver and spleen and analysed by ﬂow cytometry for the expression of adhesion molecules. NK cells (NK1.1+CD3−)w e r eg a t e d ,
and each marker was analysed by histogram. In each independent experiment, six to seven fetal mouse livers or spleens were put together to
acquire enough cells to perform FACS analysis in one experiment, and three independent experiments were performed. In the other groups,
there were three mice independently detected for one experiment, and three independent experiments were performed. The expression of
CD11c (a) and CD73 (b) on liver NK cells is shown and compared with spleen NK cells during ontogeny. The mean ﬂuorescence intensity
(MFI) and percentage of each marker is shown as the mean ± SEM from three mice in each group. These are from a single experiment
representative of three independent experiments. ∗∗∗P<0.001, ∗∗P<0.01, ∗P<0.05 compared with the corresponding group.
which diﬀered from liver NK cells during mouse ontogeny.
The CD27−CD11b− NK cells were the most immature NK
cells which can develop into the other three subset NK cells.
As reported, NK cells can develop along DN (CD27−
CD11b−) → CD27+CD11b
− → DP (CD27+CD11b
+) →
CD27
−CD11b+model [16]. However, studies of physiologi-
cal functions of these four NK subsets were limited. It has
been reported that CD27+CD11b+ exhibited stronger cyto-
toxicity and produced more IFN-γ than CD27−CD11b+ NK
cells in response to cytokine stimulation [19]. In the liver,
there may be a unique developmental pathway distinct from
the spleen such that NK cell subsets at diﬀerent maturationClinical and Developmental Immunology 9
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Figure 6: Neonatal liver NK cells produced more IFN-gamma, perforin, and Granzyme B than 10-week-old liver NK cells after stimulated
with Poly I: C in vitro. In each independent experiment, six to seven neonatal mouse livers/spleens were put together to acquire enough cells
to perform FACS analysis. NK cells (NK1.1+CD3−) were gated, and then each marker was analyzed by histogram. Unstained controls are the
grey. (a) Each percentage represents the net percentage (%) of cells in the appropriate quadrant. (b) The percentages of the IFN-gamma+
NK cell subset (%) were calculated for the total number of NK cells in the liver and spleen. Data are shown as mean ± SEM three mice in
each group. ∗∗∗P<0.001, ∗∗P<0.01, ∗P<0.05 compared with the corresponding group.
stages distribute speciﬁcallyto liver and spleen during mouse
ontogeny.
The inhibitory NKG2A and Ly49 receptors can be con-
sidered markers of the NK cell maturation stage. In fetal and
neonatal spleen, almost all NK cells express NKG2A, and the
percentage of NKG2A+ NK cells decreases during mouse
ontogeny [20–22], however, NK cells do not express Ly49C/
I/F/H in early development and gradually acquire these re-
ceptors[21,23,24].Thesamekineticsoftheexpressionlevels
of NKG2A and Ly49 receptors were observed on spleen NK
cells during mouse ontogeny in our study (Figure 2). Furth-
ermore, for the ﬁrst time, we demonstrated that almost no
Ly49C/I/F/HwasexpressedonliverNKcellsinfetalandneo-
natal mice (Figure 2) and that the decrease of NKG2A+ NK
cells and the increase of Ly49C/I/F/H+ N Kc e l l sw e r em u c h
slower in the liver than in the spleen during mouse ontogeny.
This resultedin a higher percentageof NKG2A+ NK cells and
a lower percentage of Ly49+ NK cells in liver compared to
spleen (Figure 2(b)). These results further indicate that the
development of NK cells does not occur concurrently in the
liver and spleen. In the liver, NK cells displayed predomi-
nantly immature phenotypes.
During mouse ontogeny, we observed that in the livers of
3-day-old mice, the percentage of CD27−CD11b− NK cells
was comparatively lower than in fetal and neonatal mice,
while the percentage of CD27−CD11b+ NK cells was higher
in the 3-day-old mice (Figure 1). Accordingly, in the liver of
3-day-old mice, NK cells had acquired the expression of
Ly49 receptors, occurring earlier than in spleen NK cells
(Figure 2). These results indicate that NK cells in the liver
undergo a rapid progression of development and diﬀeren-
tiation after birth. In view of special double blood supplies
from the hepatic artery and the portal vein, the liver is
continuously exposed to large amounts of intestinal antigens
after birth [25–27]. The development of liver NK cells dur-
ing early mouse ontogeny might relate to the special phys-
iological functions of the liver. We found that the expres-
sion of NKG2D rapidly increased to its highest level at 4
weeks and that the expression of CD69 was upregulated
to its highest level at 3 weeks, indicating an activated pheno-
type of liver NK cells. However, intrahepatic NK cells ex-
pressed lower levels of NKp46 and CD2 if compared with
spleen NK cells during mouse ontogeny (Figures 3 and 4).
The liver with speciﬁc blood supply from intestines10 Clinical and Developmental Immunology
continuously encounters bacterial products and food-deri-
ved antigens. The liver must eliminate the blood toxic waste
products and endotoxins or other bacterial degradation pro-
ducts from the gut, without eliciting an immune response
in the normal condition, so the liver acts as a
complex immune organ, functioning as a site of eﬀective
immune responses or of tolerance appropriately [28, 29].
The constitutive presence of non-self and microbial mole-
cules may result in the activated statement of hepatic NK
cells, which is related to the liver tolerance. It was evidenc-
ed that the liver’s resident immune cells exist in a state of
active tolerance and this state of tolerance may be revers-
ed by the right combinational administration with immuno-
stimulants. Furthermore, it has been speculated that the high
content of organ-speciﬁc NK cells might be associated with
liver immune tolerance. In humans, it has been proposed
that the unique properties of the transferred hepatic NK cells
from a donor may enable them to play a role in regu-
lating the immunological response of the recipient against
the graft and therefore contribute to liver tolerogenicity after
liver transplantation [30].
The liver is a lymphoid organ with a predominantly in-
nate immune system [31, 32]. NK cells are abundant in the
normal liver, accounting for approximately one-third of in-
trahepatic lymphocytes, which diﬀers from other lymphoid
organs and peripheral blood [25, 33, 34]. NK cells sequen-
tially express diﬀerent integrins over the course of develop-
ment and maturation [5] and alter their expression of integ-
rins and chemotactic receptors for their redistribution from
the bone marrow and lymph nodes to blood, spleen, liver,
and lung [35]. In our study, we found a constantly elevated
level of CD11c and CD73 expression on liver NK cells com-
pared to spleen NK cells during mouse ontogeny (Figures
5(a) and 5(b)). These adhesion molecules may play a role in
intrahepatic NK cell adherence and retention in the liver.
In this study, the development of intrahepatic NK cells
was described and compared to spleen NK cells during
mouse ontogeny. Our results indicate that in the liver, there
might be a speciﬁc developmental pathway of NK cells and
that the microenvironments play important roles in NK cell
development and diﬀerentiation. Further research on the
mechanisms of diﬀerentiation and activation, chemoattrac-
tion, adhesion, and functions of hepatic NK cells is war-
ranted.
4.MaterialsandMethods
4.1. Animals. C57BL/6 mice were obtained from the Shang-
hai Experimental Animal Center (Shanghai, China) and
maintainedunderspeciﬁcpathogen-freeandcontrolledcon-
ditions (22◦C, 55% humidity, and 12-hour day/night rhy-
thm). The animal experiments were performed in compli-
ance with the guidelines outlined in the Guide for the Care
and Use of Laboratory Animals. All procedures were in com-
pliance with the regulations of animal care of University of
Science and Technology of China. The accreditation number
of the laboratory is SYXK (Anhui) 2005-004 from Anhui Sci-
ence and Technology Department. All the surgery was per-
formed under sodium pentobarbital anesthesia, and all ef-
fortsweremadetominimizesuﬀering.Toobtaintimedpreg-
nant mice, mice were mated for 15 hours, and then at E20
(plugdate =day0)thefoetuseswereacquired.Neonatalmice
were 24 hours old.
The protocols regarding the use and care of animals in
theresearchasdescribedbythepaperhadbeenreviewedand
approved by the Intuitional Animal Care and Use Committee
of University of Science and Technology of China (the date of
approval: March 15, 2009, the reference number of approval:
USTCAU200900005).
4.2. Isolation of Liver Mononuclear Cells. Liver mononuclear
cells(MNCs)wereisolatedessentiallyasdescribedpreviously
[36]. Brieﬂy, mouse liver was removed and pressed through
a200-gaugestainlesssteelmesh.Thelivercellsuspensionwas
collectedandthencentrifugedat50gfor1min.Supernatants
containing MNCs were collected and washed in phosphate-
buﬀered saline (PBS). The cells were resuspended in 40%
Percoll (GE Healthcare) and then gently overlaid on 70%
Percollandcentrifugedat1260gfor30minutesatroomtem-
perature. The interface cells between the Percoll solutions
were aspirated and washed twice in PBS. Six to seven fetal
mouse livers were harvested together, and the liver MNCs
were isolated as described above.
4.3. Isolation of Splenocytes. Mouse spleen was removed and
pressed through a 200-gauge stainless steel mesh. The cell
suspension was collected and centrifuged at 890g for 10min,
and then the cells were subjected to red blood cell lysis before
incubation in PBS. Six to seven fetal mouse spleens were har-
vested together for splenocyte isolation.
4.4. Flow Cytometry Analysis. For the intracellular cytokine
assay,MNCswereculturedinthepresenceof6uMmonensin
(Sigma Chemical Co., St. Louis, MO) for 4h in humidiﬁed
5% CO2 at 37◦C. After blocking with anti-FcR, cells were
subsequently stained with a saturating amount of the indi-
cated ﬂuorescence-labelled antibodies for 30min at 4◦Ci n
darkness for the surface antigens. Subsequently, cells were
ﬁxed and permeabilized using 100uL of cytoﬁx and cytop-
erm solution (eBioscience, San Diego, Calif, USA), respec-
tively,andthenstainedwiththeindicatedﬂuorescence-label-
led antibodies for 1 hour at 4◦C in darkness for the intra-
cellular antigens. Stained cells were washed twice in PBS and
then acquired with an LSRII (Becton Dickinson) and anal-
ysed with WinMDI 2.9 software.
4.5. Reagents. The ﬂuorescence-labelled antibodies used in
this study included FITC-anti-CD69 (clone H12F3), FITC-
anti-CD11c (clone HL3), FITC-anti-CD11b (clone M1/70),
FITC-anti-AHIgG1, FITC-anti-RatIgG2b, PE-anti-CD27
(clone LG.3A10), PE-anti-NKG2D (clone CX5), PE-anti-
CD244 (clone 2B4), PE-anti-CD2 (clone RM2-5), PE-anti-
AHIgG1, PE-anti-RatIgG2a, PE-anti-RatIgG1, PE-anti-
MsIgG2b, PE-anti-RatIgG2b, PE-anti-IFN-gamma (cloneClinical and Developmental Immunology 11
XMG1.2), PerCP-Cy5.5-anti-NK1.1, PerCP-Cy5.5-anti-
MsIgG2a, APC-anti-CD3e (clone 1452C11), APC-anti-
AHIgG1, APC-anti-IgM, Alexa647-anti-RatIgG2a, APC-
Cy7-anti-CD3e (clone 145-2C11), APC-Cy7-anti-AHIgG1
(BD Pharmingen, San Diego, Calif, USA), PE-anti-NKG2A
(clone 16a11), FITC-anti-Ly49C/I/F/H (clone 14B11), PE-
anti-CD73 (clone TY/11.8), PE-anti-perforin (clone
eBioOMAK-D), PE-anti-Granzyme B (clone 16G6) and
Alexa647-anti-NKp46 (eBioscience, San Diego, Calif, USA).
RBC lysis buﬀer was purchased from Biolegend (San Diego,
Calif, USA).
4.6. Statistical Analysis. The results were analysed by Stu-
dent’s t-test, performed with GraphPad Prism v5.00 soft-
ware. All data are shown as the mean ± standard error of the
mean (SEM). P<0.05 was considered statistically signiﬁ-
cant.
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